Press Releases Year All202620252024202320222021202020192018201720162015 January 5, 2026 NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo ® Transcranial Magnetic Stimulation (TMS) machines nationwide. Program will unite common treatment protocols and clinical training with neurocare expertise in Read More Corporate Presentation Click here to view our corporate presentation or on the image below IP Portfolio View Our Pipeline Contact NRx Pharmaceuticals
Year All202620252024202320222021202020192018201720162015 January 5, 2026 NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo ® Transcranial Magnetic Stimulation (TMS) machines nationwide. Program will unite common treatment protocols and clinical training with neurocare expertise in Read More
January 5, 2026 NRx Pharmaceuticals (Nasdaq:NRXP) and neurocare Group AG Announce Joint Offering of Neuroplastic Therapy Targeting Depression, PTSD, and other mental health afflictions Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base of 400+ Apollo ® Transcranial Magnetic Stimulation (TMS) machines nationwide. Program will unite common treatment protocols and clinical training with neurocare expertise in Read More
